BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20977127)

  • 1. Management of trauma-induced coagulopathy: trends and practices.
    D'Angelo MR; Dutton RP
    AANA J; 2010 Feb; 78(1):35-40. PubMed ID: 20977127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa to correct coagulopathy in patients with traumatic brain injury presenting to outlying facilities before transfer to the regional trauma center.
    Brown CV; Sowery L; Curry E; Valadka AB; Glover CS; Grabarkewitz K; Green T; Hail S; Admire J
    Am Surg; 2012 Jan; 78(1):57-60. PubMed ID: 22273315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma.
    Stein DM; Dutton RP; Kramer ME; Scalea TM
    J Trauma; 2009 Jan; 66(1):63-72; discussion 73-5. PubMed ID: 19131807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose recombinant factor VIIa for trauma patients with coagulopathy.
    Stein DM; Dutton RP; Hess JR; Scalea TM
    Injury; 2008 Sep; 39(9):1054-61. PubMed ID: 18656871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
    Dickneite G; Dörr B; Kaspereit F; Tanaka KA
    J Trauma; 2010 May; 68(5):1151-7. PubMed ID: 19996804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current world literature. Trauma and transfusion.
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):321-5. PubMed ID: 19399963
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of recombinant-activated factor VII in bleeding trauma patients.
    Dutton RP; Conti BM
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):299-304. PubMed ID: 19295430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant activated factor VII to treat the acquired coagulopathy of trauma.
    Holcomb JB
    J Trauma; 2005 Jun; 58(6):1298-303. PubMed ID: 15995488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant factor VIIa is effective at reversing coagulopathy in a lactic acidosis model.
    Lesperance RN; Lehmann RK; Harold DM; Beekley AC; Sebesta JA; Martin MJ
    J Trauma Acute Care Surg; 2012 Jan; 72(1):123-9. PubMed ID: 22002618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIIa for correction of traumatic coagulopathy.
    Dutton RP; McCunn M; Hyder M; D'Angelo M; O'Connor J; Hess JR; Scalea TM
    J Trauma; 2004 Oct; 57(4):709-18; discussion 718-9. PubMed ID: 15514523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
    Rizoli SB; Boffard KD; Riou B; Warren B; Iau P; Kluger Y; Rossaint R; Tillinger M;
    Crit Care; 2006; 10(6):R178. PubMed ID: 17184516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time for changing coagulation management in trauma-related massive bleeding.
    Fries D; Innerhofer P; Schobersberger W
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):267-74. PubMed ID: 19390253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor IX complex for the correction of traumatic coagulopathy.
    Joseph B; Amini A; Friese RS; Houdek M; Hays D; Kulvatunyou N; Wynne J; O'Keeffe T; Latifi R; Rhee P
    J Trauma Acute Care Surg; 2012 Apr; 72(4):828-34. PubMed ID: 22491593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulopathy: its pathophysiology and treatment in the injured patient.
    Tieu BH; Holcomb JB; Schreiber MA
    World J Surg; 2007 May; 31(5):1055-64. PubMed ID: 17426904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant factor VIIa in trauma patients with the 'triad of death'.
    Mitra B; Cameron PA; Parr MJ; Phillips L
    Injury; 2012 Sep; 43(9):1409-14. PubMed ID: 21345431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients.
    Brown CV; Foulkrod KH; Lopez D; Stokes J; Villareal J; Foarde K; Curry E; Coopwood B
    J Trauma; 2010 Feb; 68(2):348-52. PubMed ID: 20154547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and laboratory response to recombinant factor VIIA in trauma and surgical patients with acquired coagulopathy.
    McMullin NR; Kauvar DS; Currier HM; Baskin TW; Pusateri AE; Holcomb JB
    Curr Surg; 2006; 63(4):246-51. PubMed ID: 16843774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulopathy in trauma patients: what are the main influence factors?
    Maani CV; DeSocio PA; Holcomb JB
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):255-60. PubMed ID: 19300245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy.
    Bauzá G; Hirsch E; Burke P; Quillen K
    Transfusion; 2007 Apr; 47(4):749-51. PubMed ID: 17381636
    [No Abstract]   [Full Text] [Related]  

  • 20. Trauma coagulopathy: Insights from the PROCOAG and CRYOSTAT-2 trials. Coagulation factors are not antibiotics.
    Gauss T; Bouzat P
    Anaesth Crit Care Pain Med; 2024 Jun; 43(3):101360. PubMed ID: 38395358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.